Medical Software Company Gets FDA Clearance For SpineAnalyzer

Radiological imaging software company Optasia Medical of Sudbury has received 510(k) clearance from the U.S. Food and Drug Administration to market its SpineAnalyzer systems in the U.S.

CEO Peter Steiger confirmed the FDA action, saying more details will be released shortly.

The SpineAnalyzer system is a workflow tool designed to help physicians diagnose vertebral deformities in patients at risk of osteoporosis.

[caption id="attachment_771" align="alignright" width="311" caption="Radiological imaging software company Optasia Medical of Sudbury"][/caption]

“The aging population and resulting increase in the number of patients suffering from osteoporosis is placing an ever increasing burden on healthcare systems, yet the existing tools to assist with the diagnosis of vertebral fractures are inadequate,” said Steiger in a communication with the executive group CEO Roundtable. “In 2005, over two million osteoporosis-related fractures occurred in the U.S., a number expected to reach three million by 2025. The costs related to these fractures were $16.9 billion in 2005 and they are predicted to rise to $25 billion by 2025. Despite the availability of bone densitometry and pharmacological therapies, the incidences of and costs related to osteoporosis have not decreased.”

Optasia provides workflow software for image analysis of X-rays of the spine, knee, hand and foot.

The company was formed in 2006.


Related Posts Plugin for WordPress, Blogger...
Be Sociable, Share!

About the Author

has written 1822 posts on this blog.

  • Pingback: 2/9/2011 Blogs Update « MedMill

  • Lipo

    Due to such modern equipment,doctor gets more ideas that what is problem inside of the body. Doctor easily comes to know about fracture by X-ray. Without such software it would be difficult to assist to patients for their panic pain.

Copyright © 2018 Medical Technology & Gadgets Blog All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes